Hologic Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Hologic Inc inventory turnover ratio, the Hologic Inc's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 2.18 in the first quarter 2025, HOLX's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Hologic Inc in Dec 27 2025 quarter, has decreased to 167 days, compare to 205 days, in the Sep 27 2025 quarter.

Within Healthcare sector 204 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 224, from total ranking in the fourth quarter 2025 at 1415.

HOLX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Hologic Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HOLX Inventory Turnover Ratio	(Dec 27 2025) I. Quarter	(Sep 27 2025) IV. Quarter	(Jun 28 2025) III. Quarter	(Mar 29 2025) II. Quarter	(Dec 28 2024) I. Quarter
Y / Y Inventory Growth	-2.63 %	-0.06 %	7.24 %	10.4 %	11.6 %
Y / Y Cost of Sales Growth	597.83 %	-22.17 %	-6.82 %	-84.45 %	-85.03 %
Inventory Turnover Ratio (TTM)	2.18	1.78	2.23	2.27	2.72
HOLX's Total Ranking	# 224	# 1415	# 517	# 1331	# 314
Average inventory processing period	167	205	164	160	134
Seq. Inventory Growth	1.34 %	-4.81 %	-0.42 %	1.36 %	4.02 %
Seq. Cost of Sales Growth	-71.29 %	2627.07 %	-14.58 %	4.35 %	-96.8 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Laboratories Industry	# 16
Healthcare Sector	# 205
Overall Market	# 224

Inventory Turnover Ratio Statistics
High	Average	Low
3.47	1.58	0.48
(Dec 28 2019)		(Sep 28 2013)

HOLX Company Profile >> Back to HOLX Efficiency Comparisons >> Compare HOLX Inventory Turnover Ratio to its Competitors

Financial Statements
Hologic Inc's Inventories	$ 689 Millions	Visit HOLX's Balance sheet
Hologic Inc's Cost of Revenues TTM	$ 1,528 Millions	Visit HOLX's Income Statement
What are HOLX's Sales?		Visit HOLX's Sales by Segment

Other Inventory Turnover Ratios
Hologic Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HOLX's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HOLX's Competitors
Inventory Turnover Ratio for HOLX's Suppliers
Inventory Turnover Ratio for HOLX's Customers

You may also want to know
HOLX's Sales Growth Rates	HOLX's Pe Price to earnings ratio	HOLX's Receivables Turnover Ratio	HOLX's Stock Quote
HOLX's Net Income Growth Rates	HOLX's Ps Price to Sales ratio	HOLX's Sales per Employee	HOLX's Asset Turnover Ratio
HOLX's Net Margin	HOLX's Pb Price to Book ratio	HOLX's Financial Strength Ratios	HOLX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Dec 27 2025, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Dec 27 2025	Inventories at quarter ending Dec 27 2025
Hims and Hers Health Inc	6.08	$ 614.000 Millions	$ 101 Millions
Kewaunee Scientific Corporation	6.02	$ 205.000 Millions	$ 34 Millions
Bionexus Gene Lab Corp	6.01	$ 6.124 Millions	$ 1 Millions
Nuo Therapeutics Inc	5.88	$ 1.000 Millions	$ 0 Millions
Adm Tronics Unlimited Inc	5.87	$ 2.097 Millions	$ 0 Millions
Celularity Inc	5.84	$ 20.074 Millions	$ 3 Millions
Exact Sciences Corporation	5.80	$ 984.000 Millions	$ 170 Millions
Phathom Pharmaceuticals Inc	5.75	$ 22.599 Millions	$ 4 Millions
Precision Optics Corporation Inc	5.73	$ 22.048 Millions	$ 4 Millions
Veracyte Inc	5.64	$ 127.000 Millions	$ 23 Millions
Avantor Inc	5.61	$ 4,412.800 Millions	$ 786 Millions
Align Technology inc	5.60	$ 1,323.000 Millions	$ 236 Millions
Harrow Inc	5.59	$ 67.934 Millions	$ 12 Millions
Transmedics Group Inc	5.53	$ 242.688 Millions	$ 44 Millions
Steris Plc	5.29	$ 3,257.520 Millions	$ 616 Millions
Integer Holdings Corporation	5.18	$ 1,353.000 Millions	$ 261 Millions
Bristol myers Squibb Company	5.14	$ 13,936.000 Millions	$ 2,713 Millions
Prophase Labs Inc	5.11	$ 2.955 Millions	$ 1 Millions
Ufp Technologies Inc	4.96	$ 432.000 Millions	$ 87 Millions
Integrated Biopharma Inc	4.91	$ 47.000 Millions	$ 10 Millions
Zai Lab Limited	4.87	$ 190.520 Millions	$ 39 Millions
Tactile Systems Technology Inc	4.78	$ 79.000 Millions	$ 17 Millions
Henry Schein Inc	4.74	$ 9,079.000 Millions	$ 1,916 Millions
West Pharmaceutical Services Inc	4.66	$ 1,970.000 Millions	$ 423 Millions
Incyte Corporation	4.48	$ 372.130 Millions	$ 83 Millions
Envista Holdings Corporation	4.39	$ 1,232.000 Millions	$ 281 Millions
Neuraxis Inc	4.37	$ 0.586 Millions	$ 0 Millions
Medinotec Inc	4.37	$ 4.255 Millions	$ 1 Millions
Qiagen N v	4.34	$ 735.268 Millions	$ 169 Millions
Electromed Inc	4.26	$ 14.195 Millions	$ 3 Millions

Date modified: 2026-09-08T18:07:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.